Pardes Biosciences Deck
Pardes Biosciences, an agile biopharmaceutical company, develops oral antiviral drug to treat and prevent SARS-CoV-2 infections.
This post is for subscribers only
SubscribeAlready have an account? Log in
D-Wave (QBTS) via DPCM Capital (XPOA) deck Paid Members Public
D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers.
Eve (EVEX) via Zanite Acq (ZNTE) deck Paid Members Public
Eve is the urban air mobility business created by Embraer S.A. and established as an independent company in October 2020.
